Chen K W, Hughes D C, Patel M V. "Method for the Synthesis of Dabigatran Impurity 132" [P]. US Patent, US 10689642 B2, 2025-09-11.
发明人韩伟,王建平,张德明. "A Process for Preparing High-Purity Dabigatran Impurity 132" [P]. 中国发明专利, 专利号 CN 116875427 B, 授权公告日 2017-07-10.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 达比加群杂质132 in Pharmaceutical Formulations". Phytochemistry, 2023, 2274, (8), 7294-7316.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达比加群杂质132 as an Impurity". J. Pharm. Biomed. Anal., 2016, 528, (12), 6159-6179.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Dabigatran Impurity 132 Using HRMS and NMR". J. Chromatogr. A, 2012, 1738, (3), 5329-5346.